These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 22849581)
41. Intrathecal drug delivery for pain management: recent advances and future developments. Jain S; Malinowski M; Chopra P; Varshney V; Deer TR Expert Opin Drug Deliv; 2019 Aug; 16(8):815-822. PubMed ID: 31305165 [No Abstract] [Full Text] [Related]
42. The Accuracy of Template-Guided Refill Technique of Intrathecal Pumps Controlled by Fluoroscopy: An Observational Study. Maino P; Koetsier E; Perez RS Neuromodulation; 2015 Jul; 18(5):428-32. PubMed ID: 25117195 [TBL] [Abstract][Full Text] [Related]
43. Intrathecal drug delivery 2002. Turner MS Acta Neurochir Suppl; 2003; 87():29-35. PubMed ID: 14518519 [TBL] [Abstract][Full Text] [Related]
44. Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain. Xing F; Yong RJ; Kaye AD; Urman RD Curr Pain Headache Rep; 2018 Feb; 22(2):11. PubMed ID: 29404792 [TBL] [Abstract][Full Text] [Related]
45. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain. Coffey RJ; Owens ML; Broste SK; Dubois MY; Ferrante FM; Schultz DM; Stearns LJ; Turner MS Anesthesiology; 2009 Oct; 111(4):881-91. PubMed ID: 20029253 [TBL] [Abstract][Full Text] [Related]
46. Applying a Part of the Daily Dose as Boli May Improve Intrathecal Opioid Therapy in Patients With Chronic Pain. Reck T; Chang EC; Béchir M; Kallenbach U Neuromodulation; 2016 Jul; 19(5):533-40. PubMed ID: 26856808 [TBL] [Abstract][Full Text] [Related]
47. Intrathecal Gadolinium Use for the Chronic Pain Physician. Hagedorn JM; Bendel MA; Moeschler SM; Lamer TJ; Pope JE; Deer TR Neuromodulation; 2019 Oct; 22(7):769-774. PubMed ID: 31448498 [TBL] [Abstract][Full Text] [Related]
48. Spinal mechanisms of pain and analgesia. Miljanich G; Rauck R; Saulino M Pain Pract; 2013 Feb; 13(2):114-30. PubMed ID: 22631599 [TBL] [Abstract][Full Text] [Related]
49. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain. Grider JS; Harned ME; Etscheidt MA Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477 [TBL] [Abstract][Full Text] [Related]
50. Practice Choices in Targeted Intrathecal Drug Delivery: An Online Survey Conducted by the Polyanalgesic Consensus Committee. Deer TR; Abd-Elsayed A; Falowski S; Hagedorn JM; Abejón D; Russo M; Engle A; Hah JM; Lamer TJ; Carayannopoulos AG; Hunter C; Steegers M; Pope J Neuromodulation; 2021 Oct; 24(7):1139-1144. PubMed ID: 33368847 [No Abstract] [Full Text] [Related]
51. Intrathecal analgesia: time to consider it for your patient? Shaparin N; Sim A; Pappagallo M; Gritsenko K; Carullo V; Tsukanov J; Kosharskyy B J Fam Pract; 2015 Mar; 64(3):166-72. PubMed ID: 25789343 [TBL] [Abstract][Full Text] [Related]
52. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry. Stearns LM; Abd-Elsayed A; Perruchoud C; Spencer R; Hammond K; Stromberg K; Weaver T Anesth Analg; 2020 Feb; 130(2):289-297. PubMed ID: 31567325 [TBL] [Abstract][Full Text] [Related]
53. Rationale and Recent Advances in Targeted Drug Delivery for Cancer Pain: Is It Time to Change the Paradigm? Dupoiron D; Duarte R; Carvajal G; Aubrun F; Eldabe S Pain Physician; 2022 May; 25(3):E414-E425. PubMed ID: 35652767 [TBL] [Abstract][Full Text] [Related]
54. Intrathecal drug delivery systems for cancer pain: Considerations for device type and indication. Mukhdomi T; Andrassy B; Mukhdomi J Pain Pract; 2024 Jul; 24(6):873-874. PubMed ID: 38529704 [No Abstract] [Full Text] [Related]
55. Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain. Coffey RJ; Owens ML; Broste SK; Dubois MY; Ferrante FM; Schultz DM; Stearns LJ; Turner MS Pain Med; 2010 Jul; 11(7):1001-9. PubMed ID: 20642729 [TBL] [Abstract][Full Text] [Related]
56. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425 [TBL] [Abstract][Full Text] [Related]
57. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study. Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907 [TBL] [Abstract][Full Text] [Related]
58. Intrathecal drug administration in chronic pain syndromes. Ver Donck A; Vranken JH; Puylaert M; Hayek S; Mekhail N; Van Zundert J Pain Pract; 2014 Jun; 14(5):461-76. PubMed ID: 24118774 [TBL] [Abstract][Full Text] [Related]